Energy Boost For Fatigued Cancer PatientsJune 11, 2002
Fatigue is one of the most common side effects of treatment for cancer, robbing patients of the energy to perform everyday tasks and severely impairing their quality of life.
But Italian scientists have found that giving people a substance called levocarnitine - which is taken in a pineapple flavoured drink - seems to help them recover from the effects of treatment. In their study, 90 per cent of those who received the supplement recovered from their fatigue within a week.
Scientists believe many cases of fatigue - which affects 80 per cent of patients receiving chemotherapy - occur when treatment disrupts a patient's metabolism. This depletes levels of a molecule called carnitine, which is vital for providing energy to our muscles.
Lead researcher Dr Francesco Graziano, of Urbino Hospital in Italy, comments: "After chemotherapy, many patients have low levels of carnitine in their blood and we think that's one of the reasons they feel so exhausted. It seemed logical that boosting carnitine levels with a dietary supplement might restore that lost energy. Our study was the first to take this new approach to treating fatigue and the results, although preliminary, were very encouraging."
Dr Graziano and his colleagues studied 50 patients who had reported feeling fatigue during the course of their chemotherapy. They used detailed questionnaires to assess each patient's degree of fatigue and took blood samples to measure carnitine levels.
Researchers then gave patients an energy drink containing levocarnitine, which is converted to carnitine in the body. After a week of treatment, their progress was assessed.
On average, blood carnitine levels increased by 50 per cent over the course of the week. And the questionnaires revealed that 45 of the 50 patients (90 per cent) no longer felt fatigued.
Dr Graziano adds: "The quality of life of our patients improved markedly over the course of the week, and it seems likely that the improvements were a result of the supplements they were taking.
"We now need larger-scale trials, to test the extent to which the supplement can restore patients' energy levels. It could become an important way of maintaining quality of life for patients undergoing intensive treatment for cancer."
Prof Gordon McVie of Cancer Research UK, owners of the British Journal of Cancer, says: "Treating patients more effectively doesn't just mean keeping them alive for longer; it also means preserving their quality of life.
"We are getting better at reducing the side effects associated with modern drugs, but chemotherapy still robs many patients of the energy they need to live their life to the full. A simple dietary supplement to restore a patient's zip would be a valuable step forward and these initial results are certainly encouraging."
Cancer Research UK
Related Chemotherapy Current Events and Chemotherapy News Articles
Scientists identify gene vital for rebuilding intestine after cancer treatment
The stem cells in our gut divide so fast that they create a completely new population of epithelial cells every week.
Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma
A targeted therapy already used to treat advanced skin cancer is also effective against the most common subtype of the brain tumor medulloblastoma in adults and should be considered for treatment of newly diagnosed patients, according to research led by St. Jude Children's Research Hospital.
Study finds non-genetic cancer mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Gene therapy may improve survival of patients with recurrent ovarian cancer
Use of gene therapy to deliver a protein that suppresses the development of female reproductive organs may improve the survival of patients with ovarian cancer that has recurred after chemotherapy, which happens 70 percent of the time and is invariably fatal.
New treatment options for a fatal leukemia
Acute lymphoblastic leukemia (ALL) frequently develops between the age of two and three. This leukemia has various forms, which differ through certain changes in the genetic material of the leukemia cells.
In lab tests, new therapy slows spread of deadly brain tumor cells
The rapid spread of a common and deadly brain tumor has been slowed down significantly in a mouse model by cutting off the way some cancer cells communicate, according to a team of researchers that includes UF Health faculty.
Omega-3 fatty acids may help improve treatment and quality of life in cancer patients
Adding omega-3 fatty acids to anti-tumor medications may improve treatment response and quality of life for cancer patients according to a new study by researchers at the University Hospitals of Leicester in the United Kingdom.
Chemotherapy and quality of life at the end of life
Chemotherapy for patients with end-stage cancer was associated with worse quality of life near death for patients with a good ability to still perform many life functions, according to an article published online by JAMA Oncology.
Mayo researchers decode molecular action of combination therapy for deadly thyroid cancer
In their bid to find the best combination of therapies to treat anaplastic thyroid cancer (ATC), researchers on Mayo Clinic's Florida campus demonstrated that all histone deacetylase (HDAC) inhibitors are not created equal.
Stem cell transplantation for children with rare form of leukemia improves outcomes
Researchers in the Division of Hematology, Oncology and Blood & Marrow Transplantation at Children's Hospital Los Angeles have shown greatly improved outcomes in using stem cell transplantation to treat patients with a serious but very rare form of chronic blood cancer called juvenile myelomonocytic leukemia (JMML).
More Chemotherapy Current Events and Chemotherapy News Articles